Keyword: Biotechnology

Plant Construction & Process Technology

Setting High Standards

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...

Plant Construction & Process Technology

A Partner to Relieve the Strain

28.09.2017 - Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...

Plant Construction & Process Technology

M&A in Pharma and CRO/CMO Industry

28.09.2017 - Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...

Plant Construction & Process Technology

The Case for Automation

19.09.2017 - Process and system automation has great appeal; it potentially reduces the need for manual intervention as well as increasing throughput with processes running 24-7. Most lab...

News

US Merck to Acquire German Biotech Rigontec

14.09.2017 - US drugmaker Merck has announced plans to acquire Germany-based Rigontec, regarded as a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway as a novel and...

News

Gilead to pay $12 Billion for Kite Pharma

04.09.2017 - US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...

News

Samsung Bioepis and Takeda in Biologics Pact

23.08.2017 - South Korean biopharmaceutical company Samsung Bioepis is taking its first step into novel drug development with an agreement to partner Japan’s Takeda Pharmaceutical. The move...

News

Monsanto Licenses ToolGen’s CRISPR Technology

22.08.2017 - Monsanto has signed a global licensing agreement with South Korean biotech ToolGen, gaining access to its CRISPR gene-editing technology. Financial terms were not disclosed. "This...